May 14 (Reuters)-
Xebio Holdings Co., Ltd.
CONSOLIDATED FINANCIAL HIGHLIGHTS
(in billions of yen unless specified)
Year ended Year ended Year to NEXT
Mar 31, 2021 Mar 31, 2020 Mar 31, 2022 YEAR
LATEST YEAR-AGO COMPANY COMPANY
RESULTS RESULTS FORECAST H1 FORECAST
Sales 202.44 225.31 225.34 110.98
(-10.2 pct) (-2.7 pct)
Operating 2.77 5.25 5.25 2.80
(-47.3 pct) (-9.0 pct)
Recurring 4.34 5.84 5.75 3.17
(-25.7 pct) (-13.1 pct)
Net
Net 412 mln 408 mln 2.49 1.33
(+1.0 pct) (-78.3 pct)
EPS 9.32 yen 9.23 yen 56.25 yen 30.01 yen
EPS Diluted 9.29 yen 9.20 yen
Ann Div 30.00 yen 32.50 yen 30.00 yen
-Q2 Div 15.00 yen 17.50 yen 15.00 yen
-Q4 Div 15.00 yen 15.00 yen 15.00 yen
NOTE - Xebio Holdings Co., Ltd..
*Second Net profit row denotes profit attributable to owners ofthe parent
To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=8281.T